Work

Abstract PS4-05-05: EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-05-05

Authors: D. J. Wiisniewski, D. J. Voeller, Y. A. Addissie, S. K. Deshmukh, S. K. Wu, M. B. Lustberg, D. Wangsa, D. Wangsa, K. Heselmeyer-Haddad, G. Sledge, S. Lipkowitz

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Caris Life Sciences (United States), Yale University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129428641

Cites:

Cited by:

Related to: